FARMACARD defends legality of SENASA contract

Santo Domingo.- FARMACARD defended its management of contracts with the National Health Insurance (SENASA), affirming that all agreements have been executed in strict compliance with the law while ensuring service quality. The company highlighted that between 2012 and 2020 it helped SENASA cut drug spending by nearly 40%, and under its new contract signed in February 2025, it achieved RD$129 million in savings within five months, equal to RD$25 million monthly, without affecting coverage for members.

The firm also reported uncovering irregularities, noting that 68% of prescriptions under the contributory regime came from the public system—three times higher than the usual average—suggesting possible fraud. To correct inefficiencies, FARMACARD implemented tighter controls, such as suspending unauthorized deliveries and introducing security tokens for medication purchases. These measures, it said, restored transparency and continuity in the distribution of medicines to more than 3.6 million members of the contributory plan, and 4.3 million when private insurers are included.

Founded in 2002 and with more than 1,500 partner pharmacies, FARMACARD emphasized that the capitated contract model it assumed in 2025 transfers full financial risk to the company, helping SENASA control costs, improve efficiency, and stabilize its budget. The company concluded by reaffirming its commitment to transparency, sustainability of the health system, and timely access to medicines for all affiliates.